"10.1371_journal.pone.0127584","plos one","2015-05-29T00:00:00Z","Lukas Martin; Susanne Schmitz; Rebecca De Santis; Sabine Doemming; Hajo Haase; Janine Hoeger; Lena Heinbockel; Klaus Brandenburg; Gernot Marx; Tobias Schuerholz","Department of Intensive Care and Intermediate Care, University Hospital, Aachen, Germany; Department of Food Chemistry and Toxicology, Berlin Institute of Technology, Berlin, Germany; Institute of Immunology, Medical Faculty, RWTH Aachen University, Aachen, Germany; Division of Biophysics, Forschungszentrum, Borstel, Germany","Conceived and designed the experiments: LM TS. Performed the experiments: LM SS RDS JH. Analyzed the data: LM TS SD LH. Contributed reagents/materials/analysis tools: HH KB JH. Wrote the paper: HH KB GM LM TS.","KB has a patent for the structure of the synthetic antimicrobial peptide 19-2.5 (Aspidasept, Brandenburg Antiinfektiva, Borstel, Germany): Patent-No:PCT/EP2009/002565 and is chief scientific officer of Brandenburg Antiinfektiva GmbH. TS received travel grants and lecture fees by Astellas Pharma, lecture fees by Bayer Vital, Astra-Zeneca and B. Braun Melsungen. GM has received honoraria for consulting or lecturing and restricted research grants from the following companies: BBraun, Edwards Life Sciences, Serumwerke Bernburg, Hutchinson Technology, Baxter. The competing interests do not alter the authors adherence to PLOS ONE policies on sharing data and materials.","2015","05","Lukas Martin","LM",10,TRUE,2,4,4,5,TRUE,TRUE,FALSE,0,NA,FALSE
